Nirmatrelvir and RI

The Defense Logistics Agency Troop Support Medical is seeking to procure Nirmatrelvir and Ritonavir (NSN 6505017227590), a pharmaceutical product classified under medicinal and botanical manufacturing. This Request for Quotation (RFQ) solicitation is open to all responsible sources, with quotes to be evaluated based on timely receipt and compliance with the electronic submission requirement. The solicitation was posted on April 26, 2026, with a response deadline of May 4, 2026, allowing interested vendors approximately eight days to prepare and submit their quotes. While specific evaluation criteria beyond timeliness are not detailed in this notice, suppliers should ensure their quotes address the approved source specification (NDC 00069-5321-30, vendor 86491) and demonstrate their ability to meet the expedited five-day delivery requirement. Hard copies of the solicitation are not available; all documentation and submission procedures are accessible exclusively through the online link provided.

This procurement is designated as a Total Small Business set-aside, restricting eligibility to qualified small businesses. The demand encompasses 55 total units across multiple military installations: one unit for USS Charleston (LCS 18), three units for USS George Washington (CVN 73), one unit for USS Michael Murphy (DDG 112), and 50 units for Navy Expeditionary Central Facility. All deliveries must be completed within five days of order placement, indicating an urgent supply requirement. The approved source identified in the solicitation (vendor 86491, NDC 00069-5321-30) provides baseline specifications for the pharmaceutical product. While no explicit contract value is disclosed in this notice, the scope is defined by unit quantities and delivery locations rather than dollar amount, with performance concentrated at multiple Navy vessels and a central Navy facility.